Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (1943)	1/22/2008 12:27:33 PM
From: Jibacoa	Read Replies (2) \| Respond to of 3722

INSM is up 8.75% as it tries to get back over the $0,75 level.<g> stockcharts.com It announced today that an external assessment of the MMD market could be in a range of $800M to $1.4B (The research was conducted on behalf of INSM.<g>) INSM is conducting a PIII of its IPLEX, which is a product candidate for MMD. The stock trades around 6xBV & in spite of some recent insiders buys, the short ratio increased around 7% & is about 4x its ADV. The L in Oct 2002 was $0.32 <g> Bernard